Prediction model for hyperprogressive disease in patients with advanced solid tumors received immune-checkpoint inhibitors: a pan-cancer study
Abstract Background Hyper progressive disease (HPD) describes the phenomenon that patients can’t benefit from immunotherapy but cause rapid tumor progression. HPD is a particular phenomenon in immunotherapy but lacks prediction methods. Our study aims to screen the factors that may forecast HPD and...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2023-09-01
|
| Seri Bilgileri: | Cancer Cell International |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12935-023-03070-x |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
